Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yipu Biotech is a Chinese biotechnology company specializing in the early screening and precise diagnosis of tumors through epigenetic technology. The company focuses on the development of DNA methylation detection kits for various cancers, including cervical, endometrial, and bladder cancers. Their core technology leverages specific biomarkers to provide non-invasive, highly sensitive, and specific diagnostic solutions that outperform traditional cytology in early detection. Yipu Biotech operates integrated R&D and manufacturing facilities, aiming to transform epigenetic research into clinical applications for cancer prevention and control.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Yipu Biotechnology.